Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy.
Journal Information
Full Title: Saudi Pharm J
Abbreviation: Saudi Pharm J
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
"This study was supported via funding from Prince Sattam bin Abdulaziz University Project Number PSAU/2023/R/1445. This study was supported via funding from Prince Sattam bin Abdulaziz University Project Number PSAU/2023/R/1445."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025